Letters to the Editor

Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma – a meta-analysis of 2,596 trial patients

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg
Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg
Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, Leeds
Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg
Division of Genetics and Epidemiology, The Institute of Cancer Research, London
Medical Clinic, Charité University Medicine Berlin, Berlin
Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg
Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg
Perlmutter Cancer Center, NYU Langone Health, New York
Institute of Human Genetics, University of Heidelberg, Heidelberg
Perlmutter Cancer Center, NYU Langone Health, New York
Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz
Leeds Institute of Cancer and Pathology, University of Leeds, Leeds
Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne
Division of Genetics and Epidemiology, The Institute of Cancer Research, London
Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases (NCT), University Clinic Heidelberg, Heidelberg
Department of Haematology, University of Newcastle, Newcastle Upon Tyne
Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom; Department of Haematology, The Royal Marsden Hospital, London
Haematologica Early view Jun 3, 2021 https://doi.org/10.3324/haematol.2021.278888